patented technology underlying Cypex's products
was developed at the University of Dundee
during a five year project in partnership with 15
pharmaceutical companies. It enables the expression of human
drug metabolising enzymes in bacteria without the need for large
modifications to be made to the proteins.
the release of our first recombinant cytochrome P450 (CYP) on 1st
February 2000, we have rapidly expanded our portfolio to over 100
products covering human drug-metabolising enzymes (including 19 CYPs
and 8 SULTs), murine and canine CYPs, 33 fine chemicals, and a range of
antibodies. We have also obtained the
prestigious ISO9001 quality accreditation.
on our expertise in expressing recombinant cytochrome P450s and in drug
metabolism, we also offer contract services both for custom protein
expression and the production of drug metabolites.
complement our high quality products we have maintained close links
with the University of Dundee and the industrial members of the
consortium involved in the original project. This enables Cypex
to remain at the forefront of in vitro drug
6 Tom McDonald Avenue
Tel.: (+44) (0)1382 562391
Fax: (+44) (0)1382 562394
Cypex Ltd is a company registered in Scotland with
company number 190620.
Registered Office: 30 & 34 Reform St, Dundee, DD1 1RJ, UK.
VAT Registration No.: GB 734995192